Press "Enter" to skip to content

COVID-19 booster shots now available through the Wellness Center

Graphic by Francisco Wang Yu

The Rollins Vaccine Program has expanded to include COVID-19 booster shots for eligible students, staff, and families of employees.

Effective Oct. 25, booster shots are limited to those who have received the Johnson & Johnson, Pfizer, or Moderna vaccines and are at least 18 years old. The Wellness Center currently reflects the parameters set by the CDC regarding eligibility for COVID-19 booster shots. Denise Snyder, associate director of the Wellness Center, said that the center will continue to expand booster availability to the Rollins community as directed. 

Those who have received the Pfizer and Moderna series are eligible for a booster if they fulfill one or more of the following criteria:

• 65 years and older

• 18+ who have underlying medical conditions

• 18+ who work in high-risk settings

• 18+ who live in high-risk settings

All faculty and staff are included in the above list and eligible to receive a booster. Those who have taken a Johnson & Johnson vaccine can receive a booster if they are over 18 years old. In addition, employees can make booster appointments for their family members. The Wellness Center is currently distributing Pfizer, Moderna, and Johnson & Johnson booster shots. Individuals can choose to receive any one of the booster series no matter the brand of their initial dose.

“COVID vaccination effectiveness decreases with time; therefore, a booster is indicated in specific populations or at-risk groups to help increase the overall effectiveness of the vaccine,” said Snyder.

While the Wellness Center is not yet tracking the progress of those with a booster shot on-campus, Snyder said that the center may expand its current vaccination dashboard to include booster data.

COVID-19 vaccines and booster shots are free to the Rollins community and are administered on an appointment basis. Those interested can schedule appointments on the Wellness Center’s website.

Comments are closed.